The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission
Open accessAbstract
Purpose We conducted two World Health Organization-commissioned reviews to inform use of high-flow nasal cannula (HFNC) in patients with coronavirus disease (COVID-19). We synthesized the evidence regarding efficacy and safety (review 1), as well as risks of droplet dispersion, aerosol generation, and associated transmission (review 2) of viral products. Source Literature searches were performed in Ovid MEDLINE, Embase, Web of Science, Chinese databases, and medRxiv. Review 1 : we synthesized results from randomized-controlled trials (RCTs) comparing HFNC to conventional oxygen therapy (COT) in critically ill patients with acute hypoxemic respiratory failure. Review 2: we narratively summarized findings from studies evaluating droplet dispersion, aerosol generation, or infection transmission associated with HFNC. For both reviews, paired reviewers independently conducted screening, data extraction, and risk of bias assessment. We evaluated certainty of evidence using GRADE methodology. Principal findings No eligible studies included COVID-19 patients. Review 1: 12 RCTs ( n = 1,989 patients) provided low-certainty evidence that HFNC may reduce invasive ventilation (relative risk [RR], 0.85; 95% confidence interval [CI], 0.74 to 0.99) and escalation of oxygen therapy (RR, 0.71; 95% CI, 0.51 to 0.98) in patients with respiratory failure. Results provided no support for differences in mortality (moderate certainty), or in-hospital or intensive care length of stay (moderate and low certainty, respectively). Review 2 : four studies evaluating droplet dispersion and three evaluating aerosol generation and dispersion provided very low certainty evidence. Two simulation studies and a crossover study showed mixed findings regarding the effect of HFNC on droplet dispersion. Although two simulation studies reported no associated increase in aerosol dispersion, one reported that higher flow rates were associated with increased regions of aerosol density. Conclusions High-flow nasal cannula may reduce the need for invasive ventilation and escalation of therapy compared with COT in COVID-19 patients with acute hypoxemic respiratory failure. This benefit must be balanced against the unknown risk of airborne transmission. Objectif Nous avons réalisé deux comptes rendus sur commande de l’Organisation mondiale de la santé pour guider l’utilisation de canules nasales à haut débit (CNHD) chez les patients ayant contracté le coronavirus (COVID-19). Nous avons synthétisé les données probantes concernant leur efficacité et leur innocuité (compte rendu 1), ainsi que les risques de dispersion des gouttelettes, de génération d’aérosols, et de transmission associée d’éléments viraux (compte rendu 2). Source Des recherches de littérature ont été réalisées dans les bases de données Ovid MEDLINE, Embase, Web of Science, ainsi que dans les bases de données chinoises et medRxiv. Compte rendu 1 : nous avons synthétisé les résultats d’études randomisées contrôlées (ERC) comparant les CNHD à une oxygénothérapie conventionnelle chez des patients en état critique atteints d’insuffisance respiratoire hypoxémique aiguë. Compte rendu 2 : nous avons résumé sous forme narrative les constatations d’études évaluant la dispersion de gouttelettes, la génération d’aérosols ou la transmission infectieuse associées aux CNHD. Pour les deux comptes rendus, des réviseurs appariés ont réalisé la sélection des études, l’extraction des données et l’évaluation du risque de biais de manière indépendante. Nous avons évalué la certitude des données probantes en nous fondant sur la méthodologie GRADE. Constatations principales Aucune étude éligible n’incluait de patients atteints de COVID-19. Compte rendu 1 : 12 ERC ( n = 1989 patients) ont fourni des données probantes de certitude faible selon lesquelles les CNHD réduiraient la ventilation invasive (risque relatif [RR], 0,85; intervalle de confiance [IC] 95 %, 0,74 à 0,99) et l’intensification de l’oxygénothérapie (RR, 0,71; IC 95 %, 0,51 à 0,98) chez les patients atteints d’insuffisance respiratoire. Les résultats n’ont pas démontré de différences en matière de mortalité (certitude modérée), ni de durée du séjour hospitalier ou à l’unité des soins intensifs (certitude modérée et faible, respectivement). Compte rendu 2 : quatre études évaluant la dispersion de gouttelettes et trois évaluant la génération et la dispersion d’aérosols ont fourni des données probantes de très faible certitude. Deux études de simulation et une étude croisée ont donné des résultats mitigés quant à l’effet des CNHD sur la dispersion des gouttelettes. Bien que deux études de simulation n’aient rapporté aucune augmentation associée concernant la dispersion d’aérosols, l’une a rapporté que des taux de débit plus élevés étaient associés à des régions à densité d’aérosols élevée plus grandes. Conclusion Les canules nasales à haut débit pourraient réduire la nécessité de recourir à la ventilation invasive et l’escalade des traitements par rapport à l’oxygénothérapie conventionnelle chez les patients atteints de COVID-19 souffrant d’insuffisance respiratoire hypoxémique aiguë. Cet avantage doit être soupesé contre le risque inconnu de transmission atmosphérique.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationAerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
Frat, J.-P., Thille, A. W., Mercat, A., Girault, C., Ragot, S., Perbet, S., Prat, G., Boulain, T., Morawiec, E., Cottereau, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503326 · Cited by 2,342
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure
Rochwerg, B., Brochard, L., Elliott, M. W., Hess, D., Hill, N. S., Nava, S., Navalesi, P., Antonelli, M., Brozek, J., Conti, G., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02426-2016 · Cited by 1,668
Self-citationAntonelli, M., Conti, G., Rocco, M., Bufi, M., De Blasi, R. A., Vivino, G., Gasparetto, A., & Meduri, G. U. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390703 · Cited by 1,014
Exposure to Influenza Virus Aerosols During Routine Patient Care
Bischoff, W. E., Swett, K., Leng, I., & Peters, T. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis773 · Cited by 226
Rochwerg, B., Granton, D., Wang, D. X., Einav, S., & Burns, K. E. A. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05658-2 · Cited by 178
Self-citationNi, Y.-N., Luo, J., Yu, H., Liu, D., Liang, B.-M., & Liang, Z.-A. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.07.083 · Cited by 112
Cited by
Severe covid-19 pneumonia: pathogenesis and clinical management
Attaway, A. H., Scheraga, R. G., Bhimraj, A., Biehl, M., & Hatipoğlu, U. (2021) · BMJ · doi:10.1136/bmj.n436 · Cited by 437
ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure
Oczkowski, S., Ergan, B., Bos, L., Chatwin, M., Ferrer, M., Gregoretti, C., Heunks, L., Frat, J.-P., Longhini, F., Nava, S., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01574-2021 · Cited by 388
Metadata
- Authors
- Agarwal, A., Basmaji, J., Muttalib, F., Granton, D., Chaudhuri, D., Chetan, D., Hu, M., Fernando, S. M., Honarmand, K., Bakaa, L., Brar, S., Rochwerg, B., Adhikari, N. K., Lamontagne, F., Murthy, S., Hui, D. S. C., Gomersall, C., Mubareka, S., Diaz, J. V., Burns, K. E. A., Couban, R., Ibrahim, Q., Guyatt, G. H., & Vandvik, P. O.
- Venue
- Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Published
- 2020-06-15
- Volume
- 67
- Issue
- 9
- Pages
- 1217-1248
- ISSN
- 0832-610X (ISSN-L)
- 1496-8975
- OpenAlex
- W3035761977
- Cited by
- 195
- References
- 10
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. https://app.cochat.ai/papers/10.1007/s12630-020-01740-2
- The paper
- Agarwal, A., Basmaji, J., Muttalib, F., Granton, D., Chaudhuri, D., Chetan, D., Hu, M., Fernando, S. M., Honarmand, K., Bakaa, L., Brar, S., Rochwerg, B., Adhikari, N. K., Lamontagne, F., Murthy, S., Hui, D. S. C., Gomersall, C., Mubareka, S., Diaz, J. V., . . . Vandvik, P. O. (2020). High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Canadian Journal of Anesthesia/Journal canadien d'anesthésie. https://doi.org/10.1007/s12630-020-01740-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.